Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates

International Journal of Antimicrobial Agents

Volumn 24, Issue 6, 2004, Pages 585-591

  Nijssen, S ^a   Florijn, A ^b   Bonten, M J M ^a,b,c   Schmitz, F J ^b   Verhoef, J ^b   Fluit, A C ^b  

^a Inst for Res in Extramural Med   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Beta lactam antibiotics; Enterobacteriaceae; ESBL; Resistance; SENTRY

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIMENTIN;

ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; HUMAN TISSUE; IN VITRO STUDY; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS;

AZTREONAM; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CEPHALOSPORINS; CIPROFLOXACIN; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EUROPE; HUMANS; KLEBSIELLA; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TESTS;

EID: 8844241568     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.08.008     Document Type: Article

References (21)

1. A.A. Medeiros Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics Clin Infect Dis 24 Suppl 1997 S19 S45
2. R.N. Jones, M.T.A. Croco, K.C. Kugler, M.A. Pfaller, M.L. Beach The SENTRY participants group (North America) Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagn Microbiol Infect Dis 37 2000 115 125
3. R.N. Jones Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients Am J Med 100 Suppl 6a 1996 S3 S12
4. R.N. Jones Can antimicrobial activity be sustained? An appraisal of orally administered drugs used for respiratory tract infections Diagn Microbiol Infect Dis 27 1997 21 28
5. S. Kenneth, K.S. Thomson, and C.C. Sanders A simple and reliable method to screen isolates of Escherichia coli and Klebsiella pneumoniae for the production of TEM- and SHV-derived extended spectrum β-lactamases Clin Microbiol Infect Dis 3 1997 549 553
6. P.E. Coudron, E.S. Moland, and C.C. Sanders Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical centre: seek and you may find J Clin Microbiol 35 1997 2593 2597
7. E. Vercauteren, P. Descheemaeker, M. Ieven, C.C. Sanders, and H. Goossens Comparison of screening methods of extended-spectrum β-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian hospital J Clin Microbiol 35 1997 2191 2197
8. D.M. Livermore β-Lactamases in laboratory and clinical resistance J Clin Microbiol Reviews 8 1995 557 584
9. H. Knothe, P. Shah, V. Krcmery, M. Antal, and S. Mitsuhashi Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens Infection 11 1983 315 317
10. G.A. Jacoby, and A.A. Medeiros More extended-spectrum β-lactamases Antimicrob Agents Chemother 35 1991 1697 1704
11. P.A. Bradford, C.E. Cherubin, V. Idemyor, B.A. Rasmussen, and K. Bush Multiply resistant Klebsiella pneumoniae isolates from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime- hydrolysing β-lactamases in a single isolate Antimicrob Agents Chemother 38 1994 1211 1233
12. K.S. Meyer, C. Urban, J.A. Eagan, B.J. Berger, and J.J. Rahal Nosocomial outbreak of Klebsiella infection resistant to late generation cephalosporins Ann Intern Med 119 1993 353 358
13. L.B. Rice, S.H. Willey, and G.A. Papanicolaou Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility Antimicrob Agents Chemother 34 1990 2193 2199
14. C.L. Emery, and L.A. Weymouth Detection and clinical significance of extended-spectrum beta-lactamases in tertiary-care medical centre J Clin Microbiol 35 1997 2061 2067
15. V. Jarlier, G. Nicolas, G. Fournier, and A. Philippon Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns Rev Infect Dis 10 1988 867 878
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999.
17. A. Florijn, S. Nijssen, F.J. Schmitz, J. Verhoef, and A. Fluit Comparison of Etest and double disk diffusion test for detection of extended spectrum beta-lactamases Eur J Clin Microbiol Infect Dis 21 2002 241 243
18. R.N. Jones, S.G. Jenkins, D.J. Hoban, M.A. Pfaller, and R. Ramphal In vitro efficacy of six cephalosporins tested against Enterobacteriaceae isolated in 38 North American medical centres participating in the SENTRY Antimicrobial Surveillance Program 1997-1998 Int J Antimicrob Agents 15 2000 111 118
19. P.L. Winokur, R. Canton, J.M. Casellas, and N. Legakis Variations in prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific region Clin Infect Dis 32 Suppl 2 2001 S94 S103
20. C. Mendes, A. Hsiung, and C. Kiffer Mystic study group: Evaluation of the in vitro activity of nine antimicrobials against bacterial strains isolated from patients in intensive care units in Brazil: MYSTIC Antimicrobial Surveillance Program Braz J Infect Dis 4 2000 236 244
21. J. Sirot, M.H. Nicolas-Chanoine, and H. Chardon Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: a 3-year survey in France Clin Microbiol Infect 8 2002 207 213